MedTrace Logo

Home-Ultrasound in Routine High-Risk Care of Patients With Gestational Diabetes Mellitus (GDM)

NCT07158970 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-09-18

No results posted yet for this study

Summary

This study evaluates the impact of incorporating home-ultrasound (home-US) devices into telemedicine care for patients with gestational diabetes mellitus (GDM). The study will compare satisfaction, clinical outcomes, and healthcare costs between standard high-risk pregnancy care and care augmented by home-US.

Conditions

  • Gestational Diabetes Mellitus

Interventions

DEVICE

Use of the Pulsenmore home ultrasound device for fetal assessment, guided remotely by a physician.

Standard care

Sponsors & Collaborators

  • PulseNmore

    collaborator INDUSTRY

  • Wolfson Medical Center

    lead OTHER_GOV

Principal Investigators

  • LIat Mor · Edith Wolfson Medical center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
51 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-01
Primary Completion
2027-08-31
Completion
2027-11-01

Countries

  • Israel

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07158970 on ClinicalTrials.gov